Biolytx Pharmaceuticals

About:

Biolytx Pharmaceuticals developing a drug focused on promoting wound healing and killing antibiotic resistant bacteria.

Top Investors: i2E, i2i, Inc.

Description:

Biolytx Pharmaceuticals, Corp. is a pharmaceutical technology company developed by Dr. Anne Pereira and the University of Oklahoma Health Sciences Center.

Total Funding Amount:

$1.1M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Oklahoma City, Oklahoma, United States

Founded Date:

2005-01-01

Contact Email:

info(AT)biolytxcorp.com

Founders:

H. Anne Pereira, William Hagstrom

Number of Employees:

1-10

Last Funding Date:

2015-11-06

IPO Status:

Private

Industries: